Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP

被引:206
|
作者
Haque, M. Emdadul [1 ]
Thomas, Kelly J. [2 ]
D'Souza, Cheryl [4 ]
Callaghan, Steve [1 ]
Kitada, Tohru [3 ]
Slack, Ruth S. [1 ]
Fraser, Paul [4 ]
Cookson, Mark R. [2 ]
Tandon, Anurag [4 ]
Park, David S. [1 ]
机构
[1] Univ Ottawa, Neurosci Grp, Ottawa Hlth Res Inst, Ottawa, ON K1H 8M5, Canada
[2] NIA, Neurogenet Lab, Bethesda, MD 20892 USA
[3] Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA
[4] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada
关键词
Parkinson's disease; neurodegeneration; neuroprotection;
D O I
10.1073/pnas.0705363105
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
PTEN-induced putative kinase 1 (Pink1) is a recently identified gene linked to a recessive form of familial Parkinson's disease (PD). The kinase contains a mitochondrial localization sequence and is reported to reside, at least in part, in mitochondria. However, neither the manner by which the loss of Pink1 contributes to dopamine neuron loss nor its impact on mitochondrial function and relevance to death is clear. Here, we report that depletion of Pink1 by RNAi increased neuronal toxicity induced by MPP+. Moreover, wild-type Pink1, but not the G309D mutant linked to familial PD or an engineered kinase-dead mutant K219M, protects neurons against MPTP both in vitro and in vivo. Intriguingly, a mutant that contains a deletion of the putative mitochondrial-targeting motif was targeted to the cytoplasm but still provided protection against 1-methyl-4-phenylpyridine (MPP+)/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced toxicity. In addition, we also show that endogenous Pink1 is localized to cytosolic as well as mitochondrial fractions. Thus, our findings indicate that Pink1 plays a functional role in the survival of neurons and that cytoplasmic targets, in addition to its other actions in the mitochondria, may be important for this protective effect.
引用
收藏
页码:1716 / 1721
页数:6
相关论文
共 50 条
  • [41] Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice
    Parain, K
    Marchand, V
    Dumery, B
    Hirsch, E
    BRAIN RESEARCH, 2001, 890 (02) : 347 - 350
  • [42] Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease
    Xia, XG
    Harding, T
    Weller, M
    Bieneman, A
    Uney, JB
    Schulz, JB
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) : 10433 - 10438
  • [43] Mechanisms of neurodegeneration in Parkinson's disease: keep neurons in the PINK1
    Brunelli, Francesco
    Valente, Enza Maria
    Arena, Giuseppe
    MECHANISMS OF AGEING AND DEVELOPMENT, 2020, 189
  • [44] Ukgansan Protects Dopaminergic Neurons against MPTP-Induced Neurotoxicity via the Nurr1 Signaling Pathway
    Chae, In-Cheol
    Jang, Jung-Hee
    Seol, In-Chan
    Kim, Yoon-Sik
    Park, Gunhyuk
    Yoo, Ho-Ryong
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [45] Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys
    Masilamoni, Gunasingh J.
    Bogenpohl, James W.
    Alagille, David
    Delevich, Kristen
    Tamagnan, Gilles
    Votaw, John R.
    Wichmann, Thomas
    Smith, Yoland
    BRAIN, 2011, 134 : 2057 - 2073
  • [46] PINK1 overexpression protects against cerebral ischemia through Parkin regulation
    Wen, Youliang
    Gu, Yueming
    Tang, Xiaodong
    Hu, Ziwei
    ENVIRONMENTAL TOXICOLOGY, 2020, 35 (02) : 188 - 193
  • [47] PINK1-Parkin Pathway Activity Is Regulated by Degradation of PINK1 in the Mitochondrial Matrix
    Thomas, Ruth E.
    Andrews, Laurie A.
    Burman, Jonathon L.
    Lin, Wen-Yang
    Pallanck, Leo J.
    PLOS GENETICS, 2014, 10 (05):
  • [48] Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage
    Wu, H. -M.
    Chen, S. -H.
    Hong, J. -S.
    Lu, R. -B.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S109 - S109
  • [49] Striatal dopaminergic dysfunction in autosomal recessive familial parkinsonism associated with PINK1 mutations
    Eggers, C.
    Hagenah, J.
    Klein, J. C.
    Schmidt, A.
    Brueggemann, N.
    Tadic, V.
    Kertelge, L.
    van der Vegt, J.
    Lohmann, K.
    Binkofski, F.
    von Cramon, Y.
    Siebner, H.
    Fink, G. R.
    Klein, C.
    Hilker, R.
    JOURNAL OF NEURAL TRANSMISSION, 2009, 116 (02) : 243 - 243
  • [50] Progression of subtle motor signs in PINK1 mutation carriers with mild dopaminergic deficit
    Eggers, C.
    Schmidt, A.
    Hagenah, J.
    Brueggemann, N.
    Klein, J. C.
    Tadic, V.
    Kertelge, L.
    Kasten, M.
    Binkofski, F.
    Siebner, H.
    Neumaier, B.
    Fink, G. R.
    Hilker, R.
    Klein, C.
    NEUROLOGY, 2010, 74 (22) : 1798 - 1805